Cargando…
Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer
PURPOSE: Selective internal radiation therapy (SIRT) is administered to treat tumors of the liver and is generally well tolerated. Although widely adopted for its therapeutic benefits, SIRT is rarely combined with external beam radiation therapy (EBRT) owing to the complexity of the dosimetry result...
Autores principales: | Abbott, Elliot, Young, Robert Steve, Hale, Caroline, Mitchell, Kimberly, Falzone, Nadia, Vallis, Katherine A., Kennedy, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071732/ https://www.ncbi.nlm.nih.gov/pubmed/33912733 http://dx.doi.org/10.1016/j.adro.2020.11.002 |
Ejemplares similares
-
Stereotactic body radiation therapy (SBRT) following Yttrium-90 ((90)Y) selective internal radiation therapy (SIRT): a feasibility planning study using (90)Y delivered dose
por: Mee, Stephen F, et al.
Publicado: (2023) -
Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
por: Mohamed, Mostafa, et al.
Publicado: (2015) -
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
por: Liu, Jason, et al.
Publicado: (2021) -
Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
por: Owen, Dawn, et al.
Publicado: (2015) -
Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
por: Lee, Boon Q, et al.
Publicado: (2019)